Sessioni Poster

PHARMACOEPIDEMIOLOGY

26/10/2017 / 19.00 - 21.00
1RISK OF MORTALITY BETWEEN BIOSIMILARS AND ORIGINATOR OF EPOETIN ALFA USERS IN ONCOLOGY: AN ANCILLARY COHORT STUDY
1)Trotta F. 2)Salvitti T. 3)Addis A. 4)Belleudi V.
14MANAGING CHRONIC MYELOID LEUKEMIA: REAL-WORLD EVIDENCE ON USE OF TYROSINE KINASE INHIBITORS AND RELATED SIDE EFFECTS.
1)Bettiol A. 2)Pirolo R. 3)Bolcato J. 4)Franchin G. 5)Giusti P. 6)Chinellato A.
31USE OF PROTON PUMP INHIBITORS AND RISK OF CARDIOVASCULAR EVENTS IN THE GENERAL POPULATION
1)Casula M. 2)Mozzanica F. 3)Scotti L. 4)Corrao G. 5)Tragni E. 6)Catapano AL.
58Real world data about biosimilar and originator somatropin use in clinical practice: an Italian population-based multiple databases study during the years 2009-2014
1)Ingrasciotta Y. 2)Marcianò I. 3)Giorgianni F. 4)Ientile V. 5)Chinellato A. 6)Tari DU. 7)Gini R. 8)Cannavò S. 9)Pastorello M. 10)Scondotto S. 11)Cananzi P. 12)Traversa G. 13)Trotta F. 14)Belleudi V. 15)Addis A. 16)Genazzani AA. 17)Trifirò G.
70Intravitreal anti-VEGF injections: real-world data on the pattern of use using multiple administrative healthcare databases from Southern Italy
1)Marcianò I. 2)Giorgianni F. 3)Aliquò G. 4)Scondotto G. 5)Pollina addario SW. 6)Scondotto S. 7)Cananzi P. 8)Puzo MR. 9)De sarro G. 10)De francesco A. 11)Trifirò G.
81Access to the market of medicines: three years' experience of the Sicilian Regional Drug Formulary
1)Pizzimenti V. 2)Formica D. 3)Cananzi P. 4)Spina E. 5)Aiello A. 6)D'ausilio A. 7)Corrao S. 8)Trifirò G.
96COST-EVALUATION OF FLUOROPYRIMIDINES-RELATED TOXICITIES ASSOCIATED WITH DPYD FOUR-SNPS PANEL IN PATIENTS GENOTYPE
1)Polesel J. 2)Ecca F. 3)Delle fratte C. 4)De mattia E. 5)Bignucolo A. 6)Buonadonna A. 7)De paoli A. 8)Berretta M. 9)Mini E. 10)Nobili S. 11)Toffoli G. 12)Cecchin E.
182DRUGS PRESCRIPTION AS A MEASURE OF CHRONICITY IN UNDOCUMENTED MIGRANTS
1)Bini S. 2)Fiorini G. 3)Sartorio A. 4)Rigamonti AE. 5)Cella SG.
211Adverse drug reactions in paediatrics: data of an Italian active monitoring study of adverse drug reactions in emergency departments (MEREAFaPS).
1)Crescioli G. 2)Lombardi N. 3)Lucenteforte E. 4)Bettiol A. 5)Vitiello A. 6)Marconi E. 7)Mugelli A. 8)Vannacci A.
289Ensure patients access to investigational medicines: compassionate use at the University Hospital of Catania
1)Longo L. 2)Benfatto G. 3) Gozzo L. 4) Mansueto S. 5) Vitale D.C. 6) Lazzara A. 7) Drago F.
334Drug-utilization of new oral anticoagulants and Vitamin K antagonists in atrial fibrillation: a retrospective study within the REGULUS project.
1)Marconi E. 2)Lucenteforte E. 3)Lombardi N. 4)Bettiol A. 5)Crescioli G. 6)Vitiello A. 7)Mugelli A. 8)Vannacci A.
448Pharmacoutilization of Antidiabetic drugs: local preliminary analysis within the DRUG-ON project
1)Vitiello A. 2)Lucenteforte E. 3)Lombardi N. 4)Bettiol A. 5)Crescioli G. 6)Marconi E. 7)Mugelli A. 8)Vannacci A.